NDC properties for "sulfADIAZINE 500 MG Oral Tablet" (RxCUI 198228)
About this data
The tables show NDC propoerties for sulfADIAZINE 500 MG Oral Tablet with the RxCUI 198228
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for sulfADIAZINE 500 MG Oral Tablet (RxCUI 198228)
| ANDA | ANDA040091 |
|---|---|
| ANDA | ANDA080084 |
| MMSL_CODE | BD3196 |
| MMSL_CODE | CD3196 |
| RxCUI | 198228 |
| SNOMEDCT | 324411000 |
| SPL_SET_ID | 6032d6f7-cbce-4e5d-841c-a1e24b616f91 |
| SPL_SET_ID | 8993651b-fff6-4e3f-9b60-78587bc9bcee |
| VUID | 4001177 |
| Prescribable Synonym | sulfADIAZINE 500 MG Oral Tablet |
| RXNAV_STR | sulfADIAZINE 500 MG Oral Tablet |
| RxNorm Name | sulfadiazine 500 MG Oral Tablet |
| Tallman Synonym | sulfADIAZINE 500 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 198228) |
NDC Properties
NDC Item 00185075701
| NDC 9 | 0185-0757 |
|---|---|
| NDC 10 | 0185-0757-01 |
| NDC Item | 00185075701 |
| Packaging | 100 TABLET in 1 BOTTLE (0185-0757-01) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 578135 |
| Imprint code | E757 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-05-31 |
| Marketing effective time low | 1994-07-29 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 0185-0757 |
NDC Item 00185075710
| NDC 9 | 0185-0757 |
|---|---|
| NDC 10 | 0185-0757-10 |
| NDC Item | 00185075710 |
| Packaging | 1000 TABLET in 1 BOTTLE (0185-0757-10) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 578135 |
| Imprint code | E757 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-05-31 |
| Marketing effective time low | 1994-07-29 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 0185-0757 |
NDC Item 42806075760
| NDC 9 | 42806-757 |
|---|---|
| NDC 10 | 42806-757-60 |
| NDC Item | 42806075760 |
| Packaging | 60 TABLET in 1 BOTTLE (42806-757-60) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 756292 |
| Imprint code | E757 |
| Labeler | EPIC PHARMA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-15 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 42806-757 |
NDC Item 62135084260
| NDC 9 | 62135-842 |
|---|---|
| NDC 10 | 62135-842-60 |
| NDC Item | 62135084260 |
| Packaging | 60 TABLET in 1 BOTTLE (62135-842-60) |
| ANDA | ANDA080084 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 811762 |
| Imprint code | CE;208 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | bevel edged |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 62135-842 |
NDC Item 00185075701
| NDC 9 | 0185-0757 |
|---|---|
| NDC 10 | 0185-0757-01 |
| NDC Item | 00185075701 |
| Packaging | 100 TABLET in 1 BOTTLE (0185-0757-01) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 578135 |
| Imprint code | E757 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-05-31 |
| Marketing effective time low | 1994-07-29 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 0185-0757 |
NDC Item 00185075710
| NDC 9 | 0185-0757 |
|---|---|
| NDC 10 | 0185-0757-10 |
| NDC Item | 00185075710 |
| Packaging | 1000 TABLET in 1 BOTTLE (0185-0757-10) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 578135 |
| Imprint code | E757 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-05-31 |
| Marketing effective time low | 1994-07-29 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 0185-0757 |
NDC Item 42806075760
| NDC 9 | 42806-757 |
|---|---|
| NDC 10 | 42806-757-60 |
| NDC Item | 42806075760 |
| Packaging | 60 TABLET in 1 BOTTLE (42806-757-60) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 756292 |
| Imprint code | E757 |
| Labeler | EPIC PHARMA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-15 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 42806-757 |
NDC Item 62135084260
| NDC 9 | 62135-842 |
|---|---|
| NDC 10 | 62135-842-60 |
| NDC Item | 62135084260 |
| Packaging | 60 TABLET in 1 BOTTLE (62135-842-60) |
| ANDA | ANDA080084 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 811762 |
| Imprint code | CE;208 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | bevel edged |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 62135-842 |
NDC Item 00185075701
| NDC 9 | 0185-0757 |
|---|---|
| NDC 10 | 0185-0757-01 |
| NDC Item | 00185075701 |
| Packaging | 100 TABLET in 1 BOTTLE (0185-0757-01) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 578135 |
| Imprint code | E757 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-05-31 |
| Marketing effective time low | 1994-07-29 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 0185-0757 |
NDC Item 00185075710
| NDC 9 | 0185-0757 |
|---|---|
| NDC 10 | 0185-0757-10 |
| NDC Item | 00185075710 |
| Packaging | 1000 TABLET in 1 BOTTLE (0185-0757-10) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 578135 |
| Imprint code | E757 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-05-31 |
| Marketing effective time low | 1994-07-29 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 0185-0757 |
NDC Item 42806075760
| NDC 9 | 42806-757 |
|---|---|
| NDC 10 | 42806-757-60 |
| NDC Item | 42806075760 |
| Packaging | 60 TABLET in 1 BOTTLE (42806-757-60) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 756292 |
| Imprint code | E757 |
| Labeler | EPIC PHARMA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-15 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 42806-757 |
NDC Item 62135084260
| NDC 9 | 62135-842 |
|---|---|
| NDC 10 | 62135-842-60 |
| NDC Item | 62135084260 |
| Packaging | 60 TABLET in 1 BOTTLE (62135-842-60) |
| ANDA | ANDA080084 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 811762 |
| Imprint code | CE;208 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | bevel edged |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 62135-842 |
NDC Item 00185075701
| NDC 9 | 0185-0757 |
|---|---|
| NDC 10 | 0185-0757-01 |
| NDC Item | 00185075701 |
| Packaging | 100 TABLET in 1 BOTTLE (0185-0757-01) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 578135 |
| Imprint code | E757 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-05-31 |
| Marketing effective time low | 1994-07-29 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 0185-0757 |
NDC Item 00185075710
| NDC 9 | 0185-0757 |
|---|---|
| NDC 10 | 0185-0757-10 |
| NDC Item | 00185075710 |
| Packaging | 1000 TABLET in 1 BOTTLE (0185-0757-10) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 578135 |
| Imprint code | E757 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-05-31 |
| Marketing effective time low | 1994-07-29 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 0185-0757 |
NDC Item 42806075760
| NDC 9 | 42806-757 |
|---|---|
| NDC 10 | 42806-757-60 |
| NDC Item | 42806075760 |
| Packaging | 60 TABLET in 1 BOTTLE (42806-757-60) |
| ANDA | ANDA040091 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 756292 |
| Imprint code | E757 |
| Labeler | EPIC PHARMA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-15 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 17 mm |
| Related queries | Properties for NDC 9 42806-757 |
NDC Item 62135084260
| NDC 9 | 62135-842 |
|---|---|
| NDC 10 | 62135-842-60 |
| NDC Item | 62135084260 |
| Packaging | 60 TABLET in 1 BOTTLE (62135-842-60) |
| ANDA | ANDA080084 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 811762 |
| Imprint code | CE;208 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | bevel edged |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 62135-842 |